Good morning! It's Paul and Jack here, with Tuesday's SCVR. 

Agenda -

Paul's section:

Mission (LON:TMG) - final results are out for this marketing company. Signs of impressive profit growth are a plus, but the balance sheet is cause for concern and companies in this sector are vulnerable to clients tightening the purse strings when the economy slows.

Driver (LON:DRV) - a profit warning from this construction and engineering consultancy. Immediate changes seem to have arrested the problem but the jury's out on whether this share is simply too small to be listed or worth a punt at the current price.

Jack's section:

S&u (LON:SUS) - I hold - a strong rebound following exceptional FY21 conditions. This is a well managed operator that thinks long term and prioritises its shareholders, yet the stock is neglected by the market and trades on a single-digit multiple of forecast earnings. The group is investing for growth and, while the general macro outlook is mixed, I would expect it to fare better than most.

Xlmedia (LON:XLM) - turnaround continues and the shares are up this morning. The business model was badly hit in 2018, so I have reservations over the robustness of earnings. The US sports betting market could be a very lucrative opportunity and the shares appear cheap, so I can see the bull case, but I’d need to have more confidence in the stability of this opportunity.


Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here